Drug Type Hematopoietic stem cell therapy |
Synonyms BD311 |
Target |
Mechanism VEGF stimulants(Vascular endothelial growth factor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet age-related macular degeneration | Phase 2 | CN | 11 Aug 2022 |